Hans-Christian Kolberg

11PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Nov 10, 2025
TARGIT-IORT in early breast cancer-real world evidence for a risk-adapted approach.

Hans-Christian Kolberg

|Sep 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.

Thorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch

|Sep 11, 2025
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.

Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber

|Jun 25, 2025
Using Machine Learning Approaches on Dynamic Patient-Reported Outcomes to Cluster Cancer Treatment-Related Symptoms.

Nora Asper, Hans Friedrich Witschel, Louise von Stockar

|Oct 16, 2024
Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15).

Natalia Krawczyk, Thorsten Kühn, Nina Ditsch

Pageof 2

Frequent Collaborators

4 joint publications

Jana de Boniface

4 joint publications

Oreste Davide Gentilini

3 joint publications

Thorsten Kühn

2 joint publications

Steffi Hartmann